Navigation Links
Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
Date:9/16/2008

WHITEHOUSE STATION, N.J., Sept. 16, 2008 Two-year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose- dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased indices of bone resorption compared to placebo in postmenopausal women with low BMD. The results were reported today at the 30th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR).

"Significant BMD increases were seen in the second year of treatment with odanacatib and these 24-month results confirm the positive increases seen at earlier timepoints," said Dr. Michael McClung, study investigator and director of the Oregon Osteoporosis Center in Portland, Oregon. "These data reinforce the potential of odanacatib as a novel treatment option for osteoporosis."

Odanacatib selectively inhibits the cathepsin K enzyme believed to play a central role in osteoclastic bone resorption, particularly in the degradation of the protein component of bone. Inhibition of cathepsin K is a novel approach to the treatment of osteoporosis that differs from those of currently approved treatments.

About the study

The multi-center, double-blind, randomized, placebo-controlled study evaluated doses of 3, 10, 25 or 50 mg of odanacatib administered orally, once-weekly and without regard to the timing of meals or the patient's physical position in 399 postmenopausal women with low BMD (T-scores equal to or less than -2.0 but equal to or greater than -3.5) for 24 months. Participants were provided with 5600 IU weekly, supplemental vitamin D, and 500 mg daily calcium carbonate was given to women with average daily calcium intakes of less than 1000 mg from all sources. The primary study endpoint was the LS mean change in BMD from baseline at the l
'/>"/>

Contact: Ron Rogers
908-423-6449
Merck & Co., Inc.
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cord Blood America CEO Announces Aggressive Acquisition Strategy, Increased Investor Relations Efforts, New Stem Cell Storage Models
2. Army personnel show increased risk for migraine
3. Physician Recruiting Standard Reveals Larger Populations Experiencing Increased Doctor Shortage
4. Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166%
5. Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting
6. Social Security Attorneys Prepare for Increased Baby Boomer SSI Claims
7. Sleep apnea linked to increased risk of death
8. Drinking in excess associated with increased risk for metabolic syndrome
9. New study finds smoking predicts increased stroke risk for your spouse
10. Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively
11. Responding to Increased Incidence of Obesity and Associated Health Issues, The HealthCentral Network Launches Site to Support those Struggling with Weight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has been ... business is showing its latest designs of wedding dresses and ... the company’s CEO, all the fresh new products are designed ... up to 80% off. All the clothes from LunaDress follow ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... website to improve navigation, functionality and user-friendliness. The new website ... but with better design and navigation, users can now access ... ... Neptune Beach, FL (PRWEB) May 18, ...
... Most Hispanics agree that the health of the entire ... their ownRIDGEFIELD, Conn., May 18 The economic downturn ... in the Hispanic community, with parents prioritizing their children,s ... Hispanics consider it equally important for parents to take ...
... States District Court issued a decision and order Friday ... attempt to prevent Ted Karkus, Mark Burnett, John ... McCubbin ("the Shareholder Nominees") from continuing their efforts to allow ... current board. The Federal Court,s decision followed ...
... /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,(OTC Bulletin Board: EMDY), a leading ... soybean products in China, today announced,results for the first fiscal ... Financial Highlights for the First Quarter, -- ... essentially breakeven in the ...
... on frequency of resistance development and safety presented ... and Infectious Diseases (ECCMID)SAN DIEGO, May 18 ... drugs for the treatment of serious bacterial infections, ... torezolid (TR-701), a novel antibiotic that is a ...
... Sciences, Inc. (OTC Bulletin Board: DSCI), a provider ... first quarter ended March 31, 2009. For the quarter, ... million in the first quarter 2008. The sales decrease of ... a significant weakening in the Canadian dollar and inventory rationalization ...
Cached Medicine News:Health News:International Student Insurance Announces Website Redesign 2Health News:New Research Finds Recession Has Greater Impact on Health of Parents than Children with Specific Findings on Hispanics 2Health News:New Research Finds Recession Has Greater Impact on Health of Parents than Children with Specific Findings on Hispanics 3Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 2Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 3Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 4Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 5Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 6Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 7Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 2Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 3Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 4Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 5Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 6Health News:Trius Presents New Data on Torezolid Antibiotic for Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections 2Health News:Derma Sciences Reports First Quarter 2009 Results 2Health News:Derma Sciences Reports First Quarter 2009 Results 3Health News:Derma Sciences Reports First Quarter 2009 Results 4Health News:Derma Sciences Reports First Quarter 2009 Results 5Health News:Derma Sciences Reports First Quarter 2009 Results 6
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015  Amgen (NASDAQ: AMGN ... full year 2014 financial results on Tuesday, Jan. 27, 2015, after ... followed by a conference call with the investment community at 2 ... Robert A. Bradway , chairman and chief executive officer, and other ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... Calif., Jan. 10, 2012  Nine prominent science institutions have ... and careers site for graduate level life science professionals.  ... all among the top graduate programs in the life ... Stony Brook, Louisville, Rochester, University of Texas Medical Branch, ...
... Jan. 10, 2012 The AquaLab Vapor Sorption ... scientists to better understand moisture in products and pinpoint ... by temperature and humidity changes can reveal important details ... type of measurement is called an isotherm.  ...
Cached Medicine Technology:Bio Careers Adds 9 Universities, Reaching 40 Members 2New AquaLab Vapor Sorption Analyzer Puts Isotherm Technology Within Financial Reach of Food and Pharmaceutical Scientists 2
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
Medicine Products: